Significats de anti-fibrotic agent en anglès

Pirfenidone is an anti-fibrotic agent known to reduce disease progression in IPF patients.

There is no effective treatment for the pulmonary fibrosis except lung transplantation, but an initial trial using pirfenidone, an anti-fibrotic agent, showed promising results.

New strategies for therapy of IPF followed, including anti-fibrotic agents and interferon gamma treatment.

The development of anti-fibrotic agents has been hampered, in part, by the insufficient fibrosis biomimicry provided by traditional in vitro platforms.